UnitedHealth Group reported solid Q2 growth and raised its full-year guidance, reflecting strong performance in key segments like Medicaid and Optum. Managementâ€™s optimistic outlook on future growth drivers and operational efficiencies are likely to boost investor confidence in the near term.

[1]